Role of Semaphorin 3A in Kidney Development and Diseases

被引:2
|
作者
Sang, Yizhen [1 ,2 ]
Tsuji, Kenji [1 ]
Nakanoh, Hiroyuki [1 ]
Fukushima, Kazuhiko [1 ,3 ,4 ]
Kitamura, Shinji [1 ,5 ]
Wada, Jun [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, 2-5-1 Shikata Cho, Okayama 7008558, Japan
[2] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Rheumatol & Immunol, Shanghai 200072, Peoples R China
[3] Massachusetts Gen Hosp, Ctr Syst Biol, Dept Med, Program Membrane Biol,Div Nephrol, Boston, MA 02114 USA
[4] Harvard Med Sch, Boston, MA 02114 USA
[5] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nursing Sci, Okayama 7191197, Japan
关键词
semaphorin; 3A; neuropilin-1; podocyte; diabetic nephropathy; acute kidney injury; chronic kidney injury; lupus nephritis; fibrosis; apoptosis; inflammation; PODOCYTE SHAPE; GUIDANCE CUE; INJURY; INFLAMMATION; BIOMARKERS; EXPRESSION; PREDICTS; PROMOTES; PROTEIN; PLEXINS;
D O I
10.3390/diagnostics13193038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kidney diseases are worldwide public health problems affecting millions of people. However, there are still limited therapeutic options against kidney diseases. Semaphorin 3A (SEMA3A) is a secreted and membrane-associated protein, which regulates diverse functions, including immune regulation, cell survival, migration and angiogenesis, thus involving in the several pathogeneses of diseases, including eyes and neurons, as well as kidneys. SEMA3A is expressed in podocytes and tubular cells in the normal adult kidney, and recent evidence has revealed that excess SEMA3A expression and the subsequent signaling pathway aggravate kidney injury in a variety of kidney diseases, including nephrotic syndrome, diabetic nephropathy, acute kidney injury, and chronic kidney disease. In addition, several reports have demonstrated that the inhibition of SEMA3A ameliorated kidney injury via a reduction in cell apoptosis, fibrosis and inflammation; thus, SEMA3A may be a potential therapeutic target for kidney diseases. In this review article, we summarized the current knowledge regarding the role of SEMA3A in kidney pathophysiology and their potential use in kidney diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Expression of Semaphorin 3A and Neuropilin 1 in Asthma
    Shim, Eun-Jin
    Chun, Eunyoung
    Kang, Hae-Ryun
    Cho, Sang-Heon
    Min, Kyung-Up
    Park, Heung-Woo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (10) : 1435 - 1442
  • [42] Semaphorin 3A: A key player in regulating asthma
    Toubi, E.
    ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: FROM BASIC SCIENCE TO CLINICAL MANAGEMENT, 2013, : 3 - 5
  • [43] Semaphorin 3A and VEGF promote inflammation retinopathy
    Sapieha, Przemyslaw
    Mawambo, Gaelle
    Agnieszka, Dejda
    FASEB JOURNAL, 2015, 29
  • [44] Semaphorin 3A A new player in bone remodeling
    Xu, Ren
    CELL ADHESION & MIGRATION, 2014, 8 (01) : 5 - 10
  • [45] Semaphorin 3A is a chemoattractant for cortical apical dendrites
    Polleux, F
    Morrow, T
    Ghosh, A
    NATURE, 2000, 404 (6778) : 567 - 573
  • [46] Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions
    Costa, C.
    Martinez-Saez, E.
    Gutierrez-Franco, A.
    Eixarch, H.
    Castro, Z.
    Ortega-Aznar, A.
    Ramon y Cajal, S.
    Montalban, X.
    Espejo, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (13) : 1632 - 1643
  • [47] Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury
    Ranganathan, Punithavathi
    Jayakumar, Calpurnia
    Mohamed, Riyaz
    Weintraub, Neal L.
    Ramesh, Ganesan
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 307 (02) : F183 - F194
  • [48] A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease
    Good, PF
    Alapat, D
    Hsu, A
    Chu, C
    Perl, D
    Wen, XP
    Burstein, DE
    Kohtz, DS
    JOURNAL OF NEUROCHEMISTRY, 2004, 91 (03) : 716 - 736
  • [49] Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients
    Perrotta, F. M.
    Ceccarelli, F.
    Barbati, C.
    Colasanti, T.
    Montepaone, M.
    Alessandri, C.
    Valesini, G.
    Lubrano, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (02) : 313 - 316
  • [50] Mutational Spectrum of Semaphorin 3A and Semaphorin 3D Genes in Spanish Hirschsprung patients
    Luzon-Toro, Berta
    Fernandez, Raquel M.
    Torroglosa, Ana
    Carlos de Agustin, Juan
    Mendez-Vidal, Cristina
    Isabel Segura, Dolores
    Antinolo, Guillermo
    Borrego, Salud
    PLOS ONE, 2013, 8 (01):